{{ storiesRelated.title }}

Full List Of Stories
08 Aug
Bayer buys Bluerock Therapeutics for up to $600m

Germany's Bayer said it would pay up to $600m (£493m) to take control of cell therapy developer BlueRock Therapeutics.

08 Aug
Bank of Georgia in GEL 100m loan deal for small firms

Bank of Georgia Group said its JSC Bank of Georgia unit and International Finance Corp (IFC) had signed a GEL 100m (£28m) loan agreement to support micro, small and medium sized enterprises with local currency.

08 Aug
Brexit woes, US-China trade war hit Savills profit

Brexit woes and the US-China trade spat hit interim results at upmarket real estate agent Savills as customers steered clear of making deals.

08 Aug
Evraz, steel manufacturing
Lower prices hit Evraz interims

Russian steel maker Evraz reported a 22% fall in core earnings on Thursday due to lower prices for vanadium, coking coal and steel products as the company warned of “volatile” markets in the second half.

08 Aug
Hastings H1 slumps on Ogden rate change

UK insurer Hastings reported a larger-than-expected fall in first-half profits after booking a charge to cover a change in the discount rate used to calculate personal injury claims.

08 Aug
Aviva reviewing Asia business as operating profits rise 1%

Britain's largest life and general insurer Aviva said it was reviewing the future of its Asia business as first half operating profit rose 1%.